Clinical Trial Update: Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial exploring how a Type 2 Deiodinase gene polymorphism affects treatment of hypothyroidism in thyroid cancer patients post-thyroidectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism
• Papillary Thyroid Carcinoma
• Thyroid Cancer

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Thyroid Cancer, Papillary, Hypothyroidism | Phase 4 | Status: UNKNOWN